Escalon Medical Corp.

OTCPK:ESMC Stock Report

Market Cap: US$926.9k

Escalon Medical Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Rich DePiano

Chief executive officer

US$204.0k

Total compensation

CEO salary percentage89.2%
CEO tenure16.9yrs
CEO ownership0.003%
Management average tenureno data
Board average tenure9.2yrs

Recent management updates

No updates

Recent updates

CEO Compensation Analysis

How has Rich DePiano's remuneration changed compared to Escalon Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$188k

Jun 30 2024US$204kUS$182k

-US$177k

Mar 31 2024n/an/a

-US$297k

Dec 31 2023n/an/a

US$451k

Sep 30 2023n/an/a

US$521k

Jun 30 2023US$204kUS$182k

US$222k

Mar 31 2023n/an/a

US$257k

Dec 31 2022n/an/a

-US$624k

Sep 30 2022n/an/a

-US$671k

Jun 30 2022US$204kUS$182k

-US$34k

Mar 31 2022n/an/a

US$100k

Dec 31 2021n/an/a

US$259k

Sep 30 2021n/an/a

US$410k

Jun 30 2021US$204kUS$182k

-US$103k

Mar 31 2021n/an/a

-US$755k

Dec 31 2020n/an/a

-US$746k

Sep 30 2020n/an/a

-US$2m

Jun 30 2020US$204kUS$182k

-US$702k

Mar 31 2020n/an/a

-US$240k

Dec 31 2019n/an/a

-US$90k

Sep 30 2019n/an/a

US$367k

Jun 30 2019US$204kUS$182k

-US$302k

Mar 31 2019n/an/a

-US$243k

Dec 31 2018n/an/a

-US$378k

Sep 30 2018n/an/a

US$564k

Jun 30 2018US$194kUS$182k

US$564k

Compensation vs Market: Rich's total compensation ($USD204.00K) is below average for companies of similar size in the US market ($USD649.63K).

Compensation vs Earnings: Rich's compensation has been consistent with company performance over the past year.

CEO

Rich DePiano (58 yo)

16.9yrs

Tenure

US$204,000

Compensation

Mr. Richard J. DePiano, Jr., also known as Rich, serves as Chairman since July 2021 and has been the Chief Executive Officer, President and General Counsel of Escalon Medical Corp. since September 25, 2013...

Board Members

NamePositionTenureCompensationOwnership
Richard DePiano
President11.6yrsUS$204.00k0.0028%
$ 25.8
Lisa Napolitano
Independent Director21.3yrsUS$22.14k0%
$ 0
David Jocavini
Independent Director6.8yrsno datano data
C. Trusk
Independent Director9.2yrsno data0.0034%
$ 31.2
John Dogum
Independent Director6.8yrsno datano data

9.2yrs

Average Tenure

57yo

Average Age

Experienced Board: ESMC's board of directors are considered experienced (9.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/31 15:23
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Escalon Medical Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution